Logotype for MacroGenics Inc

MacroGenics (MGNX) investor relations material

MacroGenics Evercore ISI 8th Annual HealthCONx Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for MacroGenics Inc
Evercore ISI 8th Annual HealthCONx Conference summary4 Dec, 2025

Strategic program updates

  • Discontinued lorigerlimab in prostate cancer after interim phase 2 data failed to meet efficacy thresholds; focus shifted to ovarian and clear cell gynecological cancers.

  • LINET study for lorigerlimab in gynecologic cancers is ongoing, with international sites and updates expected mid-next year.

  • Emphasis on dual-positive T-cell targeting and improved safety profile over traditional PD-1/CTLA-4 combinations.

  • Exploring combination strategies with ADCs and checkpoint inhibitors to enhance efficacy and safety.

  • Broader franchise strategy includes potential expansion into immunologically sensitive tumor types.

ADC pipeline and development

  • B7H3 ADC program leverages Synaffix platform for improved safety and efficacy, with two expansion cohorts in solid tumors underway.

  • ADAM9 ADC program advanced to a second-generation molecule (O28) with no observed ocular toxicity, targeting GI and other solid tumors.

  • Third ADC targets an undisclosed antigen, aiming for first-in-class status with IND planned for next year.

  • Combination regimens under consideration, including with T cell engagers and PARP inhibitors.

  • Clinical data for first two ADCs anticipated next year, with ongoing dose escalation and expansion.

Financial position and outlook

  • Q3 cash balance was $146 million, with an additional $75 million from collaborations recognized in Q4.

  • Cash runway extended into late 2027, supporting execution of clinical and strategic plans.

  • Well-resourced to deliver on upcoming data inflection points and program milestones.

LORIKEET study's specific rPFS threshold
B7H3 ADC: Differentiated development strategy
ADC platform's key differentiation points
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next MacroGenics earnings date

Logotype for MacroGenics Inc
Q4 20256 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next MacroGenics earnings date

Logotype for MacroGenics Inc
Q4 20256 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

MacroGenics Inc. is a biopharmaceutical company focused on developing and commercializing antibody-based therapies for the treatment of cancer and other serious diseases. The company's pipeline includes immuno-oncology therapies designed to harness the immune system to target and destroy cancer cells. MacroGenics employs its proprietary antibody platforms to create innovative treatments that address unmet medical needs in oncology and other therapeutic areas. The company is headquartered in Rockville, Maryland, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage